Browsing by Sponsor/Funder Sanofi Aventis
Showing results 1 to 2 of 2
| Issue Date | Title | Author(s) |
| 14-Nov-2017 | LDL-Cholesterol Lowering for the Primary Prevention of Cardiovascular Disease Among Men with Primary Elevations of LDL-Cholesterol Levels of 190 mg/dL or Above: Analyses from the WOSCOPS 5-year Randomised Trial and 20-year Observational Follow-Up. | Vallejo-Vaz, AJ; Robertson, M; Catapano, AL; Watts, GF; Kastelein, JJ, et al |
| 29-May-2018 | Response by Vallejo-Vaz et al to Letters Regarding Article, "Low-Density Lipoprotein Cholesterol Lowering for the Primary Prevention of Cardiovascular Disease Among Men With Primary Elevations of Low-Density Lipoprotein Cholesterol Levels of 190 mg/dL or Above: Analyses From the WOSCOPS (West of Scotland Coronary Prevention Study) 5-Year Randomized Trial and 20-Year Observational Follow-Up". | Vallejo-Vaz, AJ; Packard, CJ; Ray, K; |